Colorectal cancer patients whose cancer had spread to their livers benefited from surgery during which heated chemotherapy was pumped directly to their livers. Isolated hepatic perfusion (IHP) shrank tumors and increased survival time. It may be a hopeful new approach to treating colorectal cancer that is widespread in the liver.
Median survival time after the treatment was a little over 17 months. A third of patients lived two years or more.
A clinical trial of a similar hepatic perfusion technique without open surgery is currently available at the NIH Clinical Center in Bethesda, Maryland. Read the rest of this entry »